Evidence map›Paper›PMID 35831792›Full record

ArticleBMC bioinformatics2022

DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph.

Chenye Wang, Junhan Shi, Jiansheng Cai, Yusen Zhang, Xiaoqi Zheng, Naiqian Zhang

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Chenye Wang *School of Mathematics and Statistics, Shandong University, Weihai, 264209, China.ORCID http://orcid.org/0000-0001-5033-5376
Junhan Shi *School of Mathematics and Statistics, Shandong University, Weihai, 264209, China.ORCID http://orcid.org/0000-0001-8442-0288
Jiansheng Cai *Department of Mathematics, Weifang University, Weifang, 261061, Shandong, China.ORCID http://orcid.org/0000-0002-0919-7386
Yusen ZhangSchool of Mathematics and Statistics, Shandong University, Weihai, 264209, China.ORCID http://orcid.org/0000-0003-3842-1153
Xiaoqi ZhengDepartment of Mathematics, Shanghai Normal University, Shanghai, 200234, China.ORCID http://orcid.org/0000-0002-1832-4404
Naiqian ZhangSchool of Mathematics and Statistics, Shandong University, Weihai, 264209, China. nqzhang@email.sdu.edu.cn.ORCID http://orcid.org/0000-0003-0800-0016
Shandong University · CNShanghai Normal University · CNWeifang University · CN

Funding

National Natural Science Foundation of China 12071351National Natural Science Foundation of China 61877064National Natural Science Foundation of China 61972257National Natural Science Foundation of China 62072277
6 · The paper itself

Abstract

backgroundRecent advances in next-generation sequencing technologies have helped investigators generate massive amounts of cancer genomic data. A critical challenge in cancer genomics is identification of a few cancer driver genes whose mutations cause tumor growth. However, the majority of existing computational approaches underuse the co-occurrence mutation information of the individuals, which are deemed to be important in tumorigenesis and tumor progression, resulting in high rate of false positive.

resultsTo make full use of co-mutation information, we present a random walk algorithm referred to as DriverRWH on a weighted gene mutation hypergraph model, using somatic mutation data and molecular interaction network data to prioritize candidate driver genes. Applied to tumor samples of different cancer types from The Cancer Genome Atlas, DriverRWH shows significantly better performance than state-of-art prioritization methods in terms of the area under the curve scores and the cumulative number of known driver genes recovered in top-ranked candidate genes. Besides, DriverRWH discovers several potential drivers, which are enriched in cancer-related pathways. DriverRWH recovers approximately 50% known driver genes in the top 30 ranked candidate genes for more than half of the cancer types. In addition, DriverRWH is also highly robust to perturbations in the mutation data and gene functional network data.

conclusionDriverRWH is effective among various cancer types in prioritizes cancer driver genes and provides considerable improvement over other tools with a better balance of precision and sensitivity. It can be a useful tool for detecting potential driver genes and facilitate targeted cancer therapies.

Indexed as

NeoplasmsOncogenesGenomicsHigh-Throughput Nucleotide SequencingHumansMutationCancer driver genesCandidate gene prioritizationGene networkHypergraph modelRandom walkSomatic mutation

Identifiers

PMID35831792
PMCPMC9281118
OpenAlexW4285087096

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.